Recombinant full-length human MYLK2 was expressed by baculovirus in Sf9 insect cells using an N-terminal His tag.
Catalog No. M63-10H
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| M63-10H-05 | 5 ug | $226 | |
| M63-10H-10 | 10 ug | $325 | |
| M63-10H-BULK | BULK | Contact Us |
Overview:
MYLK2 is a member of the myosin light chain kinase family and is a calcium/calmodulin dependent enzyme that is exclusively expressed in adult skeletal muscle (1). MYLK2 has been proposed to participate in signaling pathways (calcium signaling pathway, focal adhesion, regulation of actin cytoskeleton) and cellular processes (neuromuscular synaptic transmission, protein/amino acid phosphorylation). MYLK2 is involved in multiple molecular functions as a result of various subdomains that participate in ATP binding, calmodulin binding, nucleotide binding, protein serine/threonine kinase activity and transferase activity) (2).
Gene Aliases:
skMLCK, KMLC, MLCK, MLCK2
Genbank Number:
References:
1. Soung, Y.H. et al:, Mutational analysis of the kinase domain of MYLK2 gene in common human cancers.Pathol Res Pract. 2006;202(3):137-40
2. Toth-Zsamboki, E. et al. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.J. Biol Chem. 2003; 21;278(47):46661-7
Specific Activity:
Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet.
|
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
|
Storage, Stability and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
~74kDa
S Saha et al., N-terminal polar amino acids of the C2 insert of nonmuscle myosin II-C2 regulate its functional properties. FEBS Letters December 2016 10.1002/1873-3468.12446
et al., Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer cell February 2020
Cardiovascular Disease, PKA/PKC Pathway, Ser/Thr Kinases
Kinase Assay Buffer I, K01-09
Kinase Dilution Buffer III, K23-09
MLCK, Active, M62-11G
LC20 Protein, M89-54G
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com